Endocrine Society Provides Guidance to FDA on Developing Drugs for Cushing's Syndrome

Dear members of the FDA Committee,

"We would like to take this opportunity to comment on the draft guidelines on Cushing’s syndrome titled above. We represent the leadership of the international Pituitary Society and the Endocrine Society and are highly experienced with pharmaceutical trials involving Cushing’s syndrome."

 Read the Full Letter